Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Source:http://linkedlifedata.com/resource/pubmed/id/15679715

Download in:

View as

General Info

PMID
15679715